London Research Institute
The Cancer Research UK London Research Institute (LRI) conducts innovative basic biological research to improve our understanding of cancer. The LRI has made significant breakthroughs since its inception, and continues to be at the forefront of its field.
With more than 550 staff and students, the LRI also has a strong academic programme and is committed to training the next generation of world-leading scientists.
Latest news
LRI scientists identify new regulatory mechanism for cytokinesisResearchers in the LRI Protein Phosphorylation group have identified a new regulatory mechanism that controls exit from cytokinesis. The discovery, published in Nature Cell Biology... Holger Gerhardt awarded Lister Prize 2008
Holger Gerhardt, group leader of LRI's Vascular Biology group, has been awarded the prestigious Lister Prize 2008. New cancer vaccine target found
LRI scientists have identified an important new protein target which could be used to produce highly focused vaccine therapies for cancer, according to research published in the Journal of Clinical Investigation...
